RegulatoryJul 10, 2026, 05:12 PM
BiomX Cancels 1.01M Shares to Regain NYSE Compliance
AI Summary
BiomX Inc. announced the cancellation of 1,013,637 restricted shares previously issued in connection with a convertible promissory note. This action was taken to regain compliance with NYSE American LLC's Section 712, which requires stockholder approval for certain transactions, including the company's acquisition of Dr. Frucht Systems Ltd. and a related line of credit. The company plans to seek stockholder approval for these transactions, though there is no assurance it will be obtained.
Key Highlights
- BiomX Inc. completed the acquisition of a 60% interest in Dr. Frucht Systems Ltd. on April 13, 2026.
- A revolving line of credit up to $2,000,000 was established with Mandragola Ltd. in connection with the acquisition.
- 1,013,637 restricted shares were issued on June 2, 2026, upon partial conversion of a $379,000 convertible note.
- NYSE American LLC deemed the acquisition and line of credit as related transactions requiring stockholder approval under Section 712.
- To regain compliance, 1,013,637 Conversion Shares were canceled on July 10, 2026, and returned to treasury.
- The company intends to seek stockholder approval for the related transactions at a future meeting.
Price Impact
More from PHGE